S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

NBSE NeuBase Therapeutics Inc

0.378

0.00 (0.00%)

After Hours

Last Updated: 18:00:00

Delayed by 15 minutes

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

NeuBase Therapeutics (NASDAQ:NBSE)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more NeuBase Therapeutics Charts.

NeuBase Therapeutics (NASDAQ:NBSE)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more NeuBase Therapeutics Charts.

NeuBase Therapeutics Inc News

Form EFFECT - Notice of Effectiveness
Tuesday 2 July 2024 (4 months ago) • Edgar (US Regulatory)

Form 15-12G - Securities registration termination [Section 12(g)]
Thursday 27 June 2024 (4 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Thursday 27 June 2024 (4 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Thursday 27 June 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 27 June 2024 (4 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 3 June 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 31 May 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 22 May 2024 (6 months ago) • Edgar (US Regulatory)

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Thursday 16 May 2024 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 13 May 2024 (6 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 6 May 2024 (6 months ago) • Edgar (US Regulatory)

NeuBase Therapeutics Announces Receipt of Notice from Nasdaq
Friday 5 April 2024 (7 months ago) • GlobeNewswire Inc.

More NeuBase Therapeutics Inc News Articles

Trump Media and Technology

AMC Entertainment

Bioelectronics (PK)

Unique Logistics (PK)

FuelCell Energy

Fannie Mae (QB)

Clean Vision (QB)

Enzolytics (PK)

NioCorp Developments

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions